These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21459257)

  • 1. Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group.
    ; Leiter LA; Fitchett DH; Gilbert RE; Gupta M; Mancini GB; McFarlane PA; Ross R; Teoh H; Verma S; Anand S; Camelon K; Chow CM; Cox JL; Després JP; Genest J; Harris SB; Lau DC; Lewanczuk R; Liu PP; Lonn EM; McPherson R; Poirier P; Qaadri S; Rabasa-Lhoret R; Rabkin SW; Sharma AM; Steele AW; Stone JA; Tardif JC; Tobe S; Ur E
    Can J Cardiol; 2011; 27(2):e1-e33. PubMed ID: 21459257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).
    ; Leiter LA; Fitchett DH; Gilbert RE; Gupta M; Mancini GB; McFarlane PA; Ross R; Teoh H; Verma S; Anand S; Camelon K; Chow CM; Cox JL; Després JP; Genest J; Harris SB; Lau DC; Lewanczuk R; Liu PP; Lonn EM; McPherson R; Poirier P; Qaadri S; Rabasa-Lhoret R; Rabkin SW; Sharma AM; Steele AW; Stone JA; Tardif JC; Tobe S; Ur E
    Can J Cardiol; 2011; 27(2):124-31. PubMed ID: 21459258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.
    Grundy SM
    J Am Coll Cardiol; 2006 Mar; 47(6):1093-100. PubMed ID: 16545636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease.
    Després JP
    J Endocrinol Invest; 2006; 29(3 Suppl):77-82. PubMed ID: 16751711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
    Misra A; Khurana L
    Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthy lifestyle factors associated with reduced cardiometabolic risk.
    Shi L; Morrison JA; Wiecha J; Horton M; Hayman LL
    Br J Nutr; 2011 Mar; 105(5):747-54. PubMed ID: 21276278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology.
    Després JP; Cartier A; Côté M; Arsenault BJ
    Ann Med; 2008; 40(7):514-23. PubMed ID: 18608131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update.
    Selwyn AP
    Am J Cardiol; 2007 Dec; 100(12A):33P-37P. PubMed ID: 18154745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options for modifying cardiometabolic risk factors.
    Aronne LJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S26-34. PubMed ID: 17320519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-2 diabetes mellitus related cardiovascular risk: new options for interventions to reduce risk and treatment goals.
    Hobbs FD
    Atheroscler Suppl; 2006 Aug; 7(4):29-32. PubMed ID: 16822723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
    Lee M; Aronne LJ
    Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of the metabolic syndrome in obesity.
    Liberopoulos EN; Mikhailidis DP; Elisaf MS
    Obes Rev; 2005 Nov; 6(4):283-96. PubMed ID: 16246214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing cardiometabolic risk: an evolving approach to patient care.
    Watson K
    Crit Pathw Cardiol; 2007 Mar; 6(1):5-14. PubMed ID: 17667880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal adiposity and cardiometabolic risk: do we have all the answers?
    Haffner SM
    Am J Med; 2007 Sep; 120(9 Suppl 1):S10-6; discussion S16-7. PubMed ID: 17720354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of appropriate patients for cardiometabolic risk management.
    Peters AL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S9-16. PubMed ID: 17934394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
    Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C
    J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.